Fig. 5
From: Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA
Further evaluation of the stack model for HCC screening. a The t-score of the stack model in normal controls, individuals with liver diseases and HCC patients. b The t-score in HCC patients with early and advanced stages. c Proportions of positive calling by the stack model and AFP (> 20 in HCC patients with early and advanced stages in the test set). d Proportions of positive calling by the stack model and PIVKA-II in HCC patients with early and advanced stages in the test set